Stalman, Eileen W
23  Ergebnisse:
Personensuche X
?
2

Persistence of seroconversion at 6 months following primary..:

Wieske, Luuk ; Stalman, Eileen W ; van Dam, P J Koos...
https://research.rug.nl/en/publications/2645b3bc-4c39-4f9a-87da-1fc0bccd69d1.  , 2023
 
?
3

Disease activity in patients with immune-mediated inflammat..:

van Dam, Koos P.J ; Wieske, Luuk ; Stalman, Eileen W...
https://research.rug.nl/en/publications/5ec1e85a-ec6c-4b98-89d2-4641ea56a756.  , 2023
 
?
4

Primary SARS-CoV-2 infection in patients with immune-mediat..:

van Dam, Koos P J ; Volkers, Adriaan G ; Wieske, Luuk...
https://research.rug.nl/en/publications/02f1078a-9d22-4978-894d-da2bdf428b09.  , 2023
 
?
6

Risk factors associated with short-term adverse events afte..:

Wieske, Luuk ; Kummer, Laura Y L ; van Dam, Koos P J...
Wieske , L , Kummer , L Y L , van Dam , K P J , Stalman , E W , van der Kooi , A J , Raaphorst , J , Löwenberg , M , Takkenberg , R B , Volkers , A G , D'Haens , G R A M , Tas , S W , Spuls , P I , Bekkenk , M W , Musters , A H , Post , N F , Bosma , A L , Hilhorst , M L , Vegting , Y , Bemelman , F J , Killestein , J , van Kempen , Z L E , Voskuyl , A E , Broens , B , Sanchez , A P , Wolbink , G , Boekel , L , Rutgers , A , de Leeuw , K , Horváth , B , Verschuuren , J J G M , Ruiter , A M , van Ouwerkerk , L , van der Woude , D , Allaart , C F , Teng , Y K O , van Paassen , P , Busch , M H , Jallah , B P , Brusse , E , van Doorn , P A , Baars , A E , Hijnen , D , Schreurs , C R G , van der Pol , W L , Goedee , H S , Steenhuis , M , Rispens , T , Ten Brinke , A , Verstegen , N J M , Zwinderman , K A H , T2B! immunity against SARS-CoV-2 study group & Eftimov , F 2022 , ' Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in pat....  , 2022
 
?
8

Breakthrough SARS-CoV-2 infections with the delta (B.1.617...:

Boekel, Laura ; Stalman, Eileen W ; Wieske, Luuk...
https://research.rug.nl/en/publications/e6bedaac-8934-4432-b0d7-f4457fddc0f1.  , 2022
 
?
11

Breakthrough SARS-CoV-2 infections with the delta (B.1.617...:

Boekel, Laura ; Stalman, Eileen W ; Wieske, Luuk...
Boekel , L , Stalman , E W , Wieske , L , Hooijberg , F , van Dam , K P J , Besten , Y R , Kummer , L Y L , Steenhuis , M , van Kempen , Z L E , Killestein , J , Volkers , A G , Tas , S W , van der Kooi , A J , Raaphorst , J , Löwenberg , M , Takkenberg , R B , D'Haens , G R A M , Spuls , P I , Bekkenk , M W , Musters , A H , Post , N F , Bosma , A L , Hilhorst , M L , Vegting , Y , Bemelman , F J , Voskuyl , A E , Broens , B , Parra Sanchez , A , van Els , C A C M , de Wit , J , Rutgers , A , de Leeuw , K , Horváth , B , Verschuuren , J J G M , Ruiter , A M , van Ouwerkerk , L , van der Woude , D , Allaart , C F , Teng , Y K O , van Paassen , P , Busch , M H , Jallah , P B P , Brusse , E , van Doorn , P A , Baars , A E , Hijnen , D J , Schreurs , C R G , van der Pol , W L , Goedee , H S , Vogelzang , E H & T2B! immunity against SARS-CoV-2 study group 2022 , ' Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with im....  , 2022
 
?
12

Breakthrough infections with the SARS-CoV-2 omicron (B.1.1...:

Stalman, Eileen W ; Wieske, Luuk ; van Dam, Koos P. J...
https://research.rug.nl/en/publications/078874c1-c88e-44f9-a4da-2846bebfb376.  , 2022
 
?
13

Risk factors associated with short-term adverse events afte..:

Wieske, Luuk ; Kummer, Laura Y L ; van Dam, Koos P J...
https://research.rug.nl/en/publications/422bea29-4172-4603-86e4-0f430a6a228b.  , 2022
 
?
15

Humoral responses after second and third SARS-CoV-2 vaccina..:

Wieske, Luuk ; van Dam, Koos P J ; Steenhuis, Maurice...
https://research.rug.nl/en/publications/2983b1d1-ec9c-4881-918f-987a2fd27816.  , 2022
 
1-15